Minerva Surgical Inc’s Lock-Up Period Will End Tomorrow (NASDAQ:UTRS)

Minerva Surgical’s (NASDAQ:UTRSGet Rating) lock-up period is set to end on Wednesday, April 20th. Minerva Surgical had issued 6,250,000 shares in its public offering on October 22nd. The total size of the offering was $75,000,000 based on an initial share price of $12.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

A number of research analysts recently weighed in on the company. Zacks Investment Research lowered Minerva Surgical from a “buy” rating to a “hold” rating in a report on Saturday, March 12th. Piper Sandler decreased their target price on Minerva Surgical from $17.00 to $12.00 and set an “overweight” rating on the stock in a report on Wednesday, March 9th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Minerva Surgical currently has a consensus rating of “Buy” and a consensus target price of $11.70.

Shares of NASDAQ UTRS opened at $4.25 on Tuesday. The company has a current ratio of 3.29, a quick ratio of 2.60 and a debt-to-equity ratio of 0.89. The firm has a fifty day moving average price of $4.90. Minerva Surgical has a one year low of $4.00 and a one year high of $10.37.

Hedge funds and other institutional investors have recently modified their holdings of the business. Millennium Management LLC acquired a new position in Minerva Surgical in the 4th quarter valued at $134,000. BlackRock Inc. bought a new stake in shares of Minerva Surgical during the 4th quarter valued at $88,000. Renaissance Technologies LLC bought a new stake in shares of Minerva Surgical during the 4th quarter valued at $78,000. Virtu Financial LLC bought a new stake in shares of Minerva Surgical during the 4th quarter worth $54,000. Finally, Perceptive Advisors LLC bought a new stake in shares of Minerva Surgical during the 4th quarter worth $451,000. 42.40% of the stock is currently owned by hedge funds and other institutional investors.

About Minerva Surgical (Get Rating)

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. Minerva Surgical is based in SANTA CLARA, Calif.

Recommended Stories

Receive News & Ratings for Minerva Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Minerva Surgical and related companies with MarketBeat.com's FREE daily email newsletter.